Published in Gut on December 01, 1997
Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. Clin Infect Dis (2009) 1.75
Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr (2010) 1.35
Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: a mathematical approach. BMC Public Health (2009) 0.78
Gender differences in diet and nutrition among adults initiating antiretroviral therapy in Dar es Salaam, Tanzania. AIDS Care (2015) 0.76
Steatorrhoea and pancreatic disease in HIV infected patients. Gut (1998) 0.75
Changes in energy expenditure resulting from altered body weight. N Engl J Med (1995) 7.03
Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis (1994) 2.63
Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med (1995) 2.50
Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr (1977) 2.36
Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients. Gut (1996) 2.26
Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med (1990) 2.21
AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med (1991) 2.13
A simplified approach of assessing adult chronic energy deficiency. Eur J Clin Nutr (1992) 1.88
Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.79
Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr (1993) 1.71
Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin Immunol Immunopathol (1989) 1.63
Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest (1989) 1.61
Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J Infect Dis (1994) 1.59
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut (1995) 1.54
Cytokine gene expression in HIV-infected intestinal mucosa. AIDS (1994) 1.37
Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr (1992) 1.29
Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut (1994) 1.28
Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr (1993) 1.22
Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology (1991) 1.09
Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09
Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection. Gastroenterology (1991) 0.99
Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr (1993) 0.93
Adaptive hyperphagia in patients with postsurgical malabsorption. Gastroenterology (1990) 0.89
Preservation of short-term energy balance in clinically stable patients with AIDS. Am J Clin Nutr (1990) 0.87
Physiological responses to slimming. Proc Nutr Soc (1991) 0.86
Interleukin-1, anorexia, and dietary fatty acids. Ann N Y Acad Sci (1990) 0.85
Effect of the energy density of a solid-liquid meal on gastric emptying and satiety. Am J Clin Nutr (1994) 0.81
Risks and benefits of home parenteral nutrition in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr (1991) 0.79
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology (2000) 2.78
Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology (1996) 2.61
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Reversible ALS-like disorder in HIV infection. Neurology (2001) 2.57
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol (1987) 2.47
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut (2005) 2.33
HIV transmission by oral sex. Lancet (1988) 2.27
The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther (2014) 2.09
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98
Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol (2001) 1.97
Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis (2000) 1.78
Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 1.73
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol (2000) 1.60
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease"). Digestion (1968) 1.56
Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut (1999) 1.56
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS (1997) 1.51
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res (2003) 1.45
Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.45
Cholangiopathy associated with Microsporidia infection of the common bile duct mucosa in a patient with HIV infection. Ann Intern Med (1992) 1.41
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
Crohn's disease clinical course and severity in obese patients. Clin Nutr (2002) 1.40
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1991) 1.28
Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol (2001) 1.27
Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther (1999) 1.27
The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr (1997) 1.26
Effects of appendicectomy on the course of ulcerative colitis. Gut (2002) 1.24
Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabetes Metab (1999) 1.24
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease. Ann Intern Med (1986) 1.22
Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet (1988) 1.21
Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis (1995) 1.20
Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. Diabetes Metab (1999) 1.19
Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1. J Virol (2000) 1.19
Drug induced lymphocytic colitis. Gut (1994) 1.13
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol (1999) 1.06
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine. Aliment Pharmacol Ther (2009) 1.04
[Inflammatory polyarthritis associated with villous atrophy of the small intestine. Study of 2 cases]. Rev Rhum Mal Osteoartic (1980) 1.04
Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. Clin Exp Immunol (1984) 1.04
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1989) 1.03
Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet (1994) 1.02
Lymphoid follicular proctitis. A condition different from ulcerative proctitis? Dig Dis Sci (1988) 1.02
Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol (2001) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax (1994) 1.00
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). HIV Med (2004) 1.00
Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther (2005) 0.99
Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? Clin Infect Dis (1996) 0.99
Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome? Clin Exp Immunol (1985) 0.99
Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol (1998) 0.99
Role of the ileocecal valve and site of intestinal resection in malabsorption after extensive small bowel resection. Digestion (1978) 0.99